Patent Term Extension Application for NUZOLVENCE® (zoliflodacin), Patent No. 9,187,495 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-3824

Patent Term Extension Application for NUZOLVENCE® (zoliflodacin), Patent No. 9,187,495

Documents

Comments

Description

OPEN

Comment Period OpensApr 9, 2026

Type	Title	Posted	Comments	Status
Other	Patent Term Extension Application from McCarter & English LLP (on behalf of Entasis Therapeutics Inc)	Apr 9, 2026	--

CDER

Patent Term Extension Application

McCarter & English LLP

Entasis Therapeutics Inc

NUZOLVENCE® (zoliflodacin)

Patent No. 9,187,495

OPEN